Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bhargavi Allu"'
Autor:
Tian Zhao, Qingtai Su, Stephen Gutowski, Austin Burcham, Irina Kalashnikova, Zirong Chen, Bhargavi Allu, Ruolan Han, Kartik Krishnan, Jason B Miller
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/80488a9dad854dabbf72452435479b21
Autor:
Qingtai Su, Stephen Gutowski, Irina Kalashnikova, Austin Burcham, Bhargavi Allu, Zirong Chen, Zhichen Sun, Jinming Gao, Ruolan Han, Jason B. Miller, Tian Zhao
Publikováno v:
Cancer Research. 83:LB001-LB001
Background: Interleukin-12 is a potent proinflammatory cytokine that proliferates and activates T cells, NK cells and differentiates Th1 cells. Translation of IL-12 for cancer treatment has been hindered by lethal toxicities due to cytokine release s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0133602c427950da624a9ab3a0c68b79
https://doi.org/10.1158/1538-7445.am2023-lb001
https://doi.org/10.1158/1538-7445.am2023-lb001
Autor:
Qingtai Su, Stephen Gutowski, Gaurav Bharadwaj, Austin Burcham, Bhargavi Allu, Irina Kalashnikova, Zirong Chen, Ruolan Han, Jason B. Miller, Tian Zhao
Publikováno v:
Cancer Research. 83:815-815
Bispecific antibodies are an emerging class of therapeutics for immune-oncology applications. T cell engagers (TCEs) target tumor-associated antigens (TAA) to eradicate cancer cells. TCEs for solid tumors have demonstrated encouraging preclinical eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f069fa33cc270c60b2fd94c5c8a646e
https://doi.org/10.1158/1538-7445.am2023-815
https://doi.org/10.1158/1538-7445.am2023-815